STOCK TITAN

Novavax to Participate in the BofA Securities 2023 Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Novavax, Inc. will participate in the BofA Securities 2023 Health Care Conference. The conference includes a fireside chat and investor meetings. The fireside session will be recorded and available for replay on the company's website.
Positive
  • Novavax's participation in the conference could generate positive investor interest and potentially increase the stock price.
Negative
  • No negative takes found.

GAITHERSBURG, Md., May 4, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will participate in the BofA Securities 2023 Health Care Conference.

Conference Details:

Fireside Chat

Date:

Thursday, May 11, 2023

Time:

10:00 – 10:30 a.m. Pacific Daylight Time (PDT)

Location:

Encore Hotel in Las Vegas, Nevada

Moderator:

Alec Stranahan, Ph.D., Equity Research Analyst – Biotechnology

Novavax participants:

John C. Jacobs, President and Chief Executive Officer and

Filip Dubovsky, M.D., President, Research & Development



Conference


Event:

Investor Meetings

Date:

Wednesday, May 10, 2023 - Thursday, May 11, 2023

Recordings
A replay of the recorded fireside session will be available through the Events & presentations page of the Company's website at ir.novavax.com for 90 days from the date of the conference.

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined.

Please visit novavax.com and LinkedIn for more information.

Contacts: 
Investors
Erika Schultz | 240-268-2022
ir@novavax.com

Media
Ali Chartan or Giovanna Chandler | 240-709-5563
media@novavax.com

Novavax Logo (PRNewsfoto/Novavax)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-the-bofa-securities-2023-health-care-conference-301816524.html

SOURCE Novavax, Inc.

FAQ

When will Novavax participate in the BofA Securities 2023 Health Care Conference?

Novavax will participate on Thursday, May 11, 2023.

What events will Novavax be involved in during the conference?

Novavax will have a fireside chat and investor meetings.

Will the fireside session be recorded?

Yes, the fireside session will be recorded and available for replay on Novavax's website.

Where can I find the replay of the fireside session?

The replay will be available on the Events & presentations page of Novavax's website at ir.novavax.com.

Novavax Inc

NASDAQ:NVAX

NVAX Rankings

NVAX Latest News

NVAX Stock Data

647.26M
125.20M
4.99%
56.33%
31.37%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
GAITHERSBURG

About NVAX

novavax, inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. our recombinant nanoparticles and matrix-m™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. product pipeline our product pipeline targets a variety of infectious diseases with vaccine candidates currently in clinical development for respiratory syncytial virus ("rsv"​), seasonal influenza, pandemic influenza, and ebola virus ("ebov"​). we have additional preclinical-stage programs for a variety of infectious diseases. corporate overview novavax is headquartered in gaithersburg, maryland with additional facilities in rockville, maryland and uppsala, sweden. novavax is traded on the nasdaq stock market under the symbol nvax and employs over 300 individuals dedicated to developing novel vaccines to address infectious disease.